Europe Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Product (Single-phase, Duplex), By Application (Wrinkle Removal, Lip Augmentation), By Country, And Segment Forecasts, 2023 - 2030

Report Overview

The Europe hyaluronic acid-based dermal fillers market size was estimated at USD 1.07 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2030. Growing social media influence and increasing geriatric population are some of the factors contributing to the growth of the market. The market is expected to further grow due to the rising medical tourism and an increase in the number of aesthetic procedures around the globe.

The number of cosmetic clinics in nations like France has increased, helping the Europe industry expand. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, a total number of 227,307 nonsurgical procedures were performed in France, of which 120,156 were hyaluronic acid procedures, which is the second most preferred noninvasive procedure. Market participants offer cutting-edge items to boost treatment effectiveness and gain a bigger market share. In Germany, Belotero Lips was introduced by Merz in 2018 for treating perioral wrinkles and lip augmentation.

With changing demographics, procedures, and products, dermatologists and physicians can customize therapies or procedures for individual patients. They opt for a combination of products for better outcomes and patient satisfaction. Botulinum toxin and hyaluronic acid dermal fillers are becoming more popular for wrinkle treatment due to increased awareness of the desirable results, ease of performing these procedures, shorter hospital stays, and rapid recovery with negligible incisions, wide product availability, and minimal adverse effects.

Aging is a significant driver of increased health care. After isolating the impact of each of the four major drivers of health spending i.e., population growth, population aging, improvements in quality of care, and inflation due to rising drug prices, physician services, hospital maintenance, and other expenses, the Conference Board estimates that population aging by itself will drive 20 percent of all health care spending growth over the next ten years.

Men are opting for cosmetic treatments such as hair restoration, cellulite removal, fat or wrinkle removal, and facial rejuvenation. This change in perception of masculine beauty can also be ascribed to men’s changing expectations in contemporary society. The aesthetic trend for men is moving toward a more youthful, toned, and bright appearance.

Application Insights

Based on application, the Europe hyaluronic acid-based dermal fillers market is segmented into wrinkle removal, lip augmentation, rhinoplasty, and others. The wrinkle removal segment held the largest market share of 28.5% in 2022 and is also expected to grow at the fastest CAGR of 8.3% over the forecast period. Hyaluronic acid fillers are gaining popularity in varied antiaging treatments. The increasing need and impulse to look young and defer the effects of aging have led to the advancement in technology, resulting in noninvasive procedures for the treatment of wrinkles.

Hyaluronic acid fillers are time-saving procedures that require no bandages or incisions and impose no restrictions after completion of the procedure. These act as substitutes for injectable fillers such as collagen because they are relatively less expensive, have a negligible risk of allergic reaction, and are more comfortable compared to injectable fillers.

Product Insights

The market in Europe can be broadly studied based on product into single-phase products and duplex products. Single-phase products accounted for around 50.0% share in 2022 and are expected to grow at the fastest CAGR over the forecast period. This is owing to technological advancements, a wide range of applications, increasing government funding for innovation, and a rise in applications of implantable devices.

Hylacross technology provides a high concentration of cross-linked hyaluronic acid molecules, resulting in the longevity of desirable effects. These are utilized for volumizing and correcting deeper folds, leading to more preferability. Desired and beneficial effects produced by single-phase products are leading to an increase in their preference among consumers.

Dermal fillers market growth has been considerably influenced by increased per capita spending on cosmetics and rising awareness of aesthetic procedures through various platforms. Personal care costs have increased due to changing human behaviors and lifestyles, rising incomes, and concern for beauty. As the population ages and people's interest in aesthetics increases, demand for dermal fillers will continue to rise. The growing popularity of aesthetic operations results from technology advancements and a wider variety of procedures being offered. Dermal fillers and other therapies and surgical and non-surgical procedures are now available to patients.

Country Insights

In 2022, Germany dominated the market and accounted for the largest share of 25.1% due to the rising aesthetic consciousness, quick improvements, and reduced process times. Italy has the largest geriatric population in Europe and accounts for the second-largest geriatric population worldwide.

The elderly and middle-aged women prefer antiaging treatments to enhance aesthetic appeal, whereas women prefer lip and cheek augmentation procedures in their twenties. Restylane, Perfectha, Juvederm, and Belotero are some of the popular hyaluronic acid dermal fillers in the UK.

Key Companies & Market Share Insights

The market is competitive and some of the companies have made significant inroads into the Europe region with the help of their excellent product pipeline and diverse portfolio. Key players are concentrating on extending their portfolios through strategic alliances, product launches, and mergers & acquisitions.

In June 2023, Croma-Pharma, a European manufacturer of HA syringes, announced the enrollment of the first patient for the clinical trial in China for the approval of Princess Volume Plus Lidocaine. The randomized, evaluator-blinded, multi-center, active-controlled, parallel-group Phase 3 trial is led by Lanhzou Biotechnique Development to confirm its safety & efficacy in mid-facial volume insufficiency and profile deficient participants.

In September 2020, Joonghun Pharmaceutical received a CE mark for 6 products of the Lorient series i.e., 3 from “Lorient Pure” and 3 from “Lorient”. Lorient is a cross-linked HA dermal filler that has established a foothold in the Europe aesthetics market by proving the quality and safety suitable for global standards with the acquisition of the European certification.

In September 2018, Allergan launched its novel, dual-acting skin care product—SkinMedica LUMIVIVE System. In April 2018, the company received approval for the treatment of the submandibular area with CoolSculpting. This approval was expanded to include patients with a BMI of 46.2 for treating submental and submandibular areas. Some prominent players in the Europe hyaluronic acid-based dermal fillers market include:

• Allergan

• Galderma Laboratories

• Merz Pharma

• Genzyme corporation

• Medicis Pharmaceutical (Bausch Health)

• Inamed Corporation

• Laboratoires VIVACY

• Bioxis Pharmaceuticals

Europe Hyaluronic Acid-based Dermal Fillers Market Report Scope

Europe Hyaluronic Acid-based Dermal Fillers Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Europe hyaluronic acid-based dermal fillers market report based on product, application, and country:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Single-phase Products

  • Duplex Products

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Wrinkle Removal

  • Lip Augmentation

  • Rhinoplasty

  • Others

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • UK

  • France

  • Germany

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway